Romania’s interim foreign minister, Oana Țoiu, announced on Monday, July 20, that the Visa Waiver program remains a priority ...

CodeeBot, a pioneer in educational technology, today announced the official launch of CodeeBot-a groundbreaking, screen-free tangible coding platform designed to make programming logic intuitive, ...

Traditionally, treatments focused on boosting serotonin levels or other neurotransmitters, resulting in long waiting periods for patients to notice any changes, without any assurance of effectiveness.

HLP003 previously granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration ("FDA”) HLP003 Phase 2 data demonstrated durable efficacy, with a mean ~23-po ...

Anyone modernizing SAP systems must also invest in the continuing education of their developers. Otherwise, according to ...

In the geopolitical crucible of the Taiwan Strait, a profound paradigm shift is underway regarding how modern deterrence is ...

Scribe Therapeutics is a Phase 1 clinical-stage biopharma developing in vivo CRISPR gene editing for disease prevention, ...

This week, Utahns will line the streets for parades featuring handcarts accompanied by women in bonnets and men in suspenders ...

USA News Group - News Commentary - Depression remains one of the most stubborn problems in modern medicine, and the numbers ...

ORNL's MEGA-DC platform helps utilities and regulators evaluate data center growth through the lenses of affordability, ...

Piedmont Atlanta Hospital has successfully treated the first patients in the Southeast in the PIANO IDE Trial. The study is testing two devices used to help treat brain aneurysms.

ENCINITAS, CALIFORNIA, July 20th, 2026, ChainwireThe California Institute for Human Science (CIHS) today announced the launch ...